期刊文献+

系统性红斑狼疮抗活化的蛋白C研究 被引量:6

Activated protein C resistance in systemic lupus erythematosus
原文传递
导出
摘要 目的 了解抗活化的蛋白C(APCR)在系统性红斑狼疮 (SLE)患者中的发生情况 ,并进一步探讨SLE患者发生血栓的机制。方法 采用APC KPTT法 ,ELISA法和PTT LA法分别对5 0例SLE患者及 2 0例正常对照 (NC)进行APCR、抗心磷脂抗体 (ACA)和狼疮抗凝物 (LA)检测。结果 SLE患者APCR阳性率 ( 5 8% )明显高于NC组 ( 5 % ) (P <0 0 0 5 ) ,APCR阳性患者中血栓发生率( 2 7 6% )明显高于APCR阴性患者 ( 4 8% ) (P <0 0 1) ,患者LA阳性率 ( 2 2 % )明显高于对照组 ( 0 /10 ) (P <0 0 5 ) ,患者ACA IgG及IgM明显高于对照组 (P <0 0 5 ) ,而IgA与对照组差异不显著 (P >0 0 5 ) ,LA阳性组中的APCR阳性率 ( 90 9% )明显高于LA阴性组 ( 5 3 8% ) (P <0 0 5 ) ,ACA阳性组中的APCR阳性率 ( 64 7% )与ACA阴性组 ( 60 6% )未发现明显相关性 (P >0 0 5 )。结论 APCR在国人SLE患者中有较高的发生率且与LA有明显相关性 ,APCR可能是SLE患者诱发血栓的主要原因之一。 Objective To know the occurrence of activated protein C resistance (APCR) in Chinese patients with systemic lupus erythematosus (SLE) and investigate the occurring mechanism of thrombosis in SLE.Methods APC KPTT assay,ELISA and PTT LA methods were used respectively to detect APCR,anticardiolipin antibodies (ACA) and lupus anticoagulants (LA) in 50 patients with SLE and 20 normal controls (NC).Results The incidence of APCR in SLE (58%) was significantly higher than that in NC group (5 0%) ( P <0 005),the incidence of thrombosis in APCR positive (27 6%) was significantly higher than in APCR negative (4 8%) ( P <0 05),the incidence of LA in SLE (22%)was significantly higher than in NC group (0/20) ( P <0 05) and the ACA IgG and IgM in SLE was higher than in NC group ( P <0 05),but there was no significant difference of ACA IgA between two groups ( P >0 05),the incidence of APCR in LA positive (90 9%) was obviously higher than in LA negative (53 8%) samples of patients with SLE ( P <0 05),but the ACA was not significantly associated with APCR ( P >0 05).Conclusion There is a few higher incidence with APCR in Chinese patients with SLE and related to LA.APCR seems to be one of the main reasons to induce the thrombosis in patients with SLE.
出处 《中华风湿病学杂志》 CAS CSCD 2000年第1期18-20,共3页 Chinese Journal of Rheumatology
基金 安徽省自然科学基金!资助项目 (98452 2 34)
关键词 系统性红斑狼疮 血栓形成 抗活化的蛋白 APCR Lupus erythematosus,systemic Antibodies,antiphospholipid Thrombosis Activated protein C resistance
  • 相关文献

参考文献10

  • 1Dahlback B,Carlsson M,Svensson PT,et al.Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated C: prediction of a cofactor to activated C[].Proceedings of the National Academy of Sciences of the United States of America.1993
  • 2Leroy-Matheroa C,Levent M,Pignon JM,et al.The 1691G→A mutation in the factor Ⅴ gene: relationship to activated protein C(PAC) resistance and thrombosis in 65 patients[].Thrombosis and Haemostasis.1996
  • 3Lockshin MD.Pregnancy loss in the antiphospholipid syndrome[].Thrombosis and Haemostasis.1999
  • 4Rosen SB,Sturk A.Activated protein C resistance-a major risk factor for the thrombosis[].European Journal of Clinical Chemistry.1997
  • 5Chaturvedi S,Dzieczkowski J.Multiple hemostatic abnormalities in young adults with activated protein C resistance and cerebral ischemia[].Journal of the Neurological Sciences.1998
  • 6Faioni EM,Razzari C,Martinelli I,et al.Resistance to activated protein C in unselected patients with arterial and venous thrombosis[].American Journal of Hematology.1997
  • 7Bokarewa MI,Bremme K,Falk G,et al.Studies on phospholipid antibodies,APC-resistance and associated mutationin the coagula-tion factor V[].Thrombosis Research.1995
  • 8Bokarewa MI,Blomback M.Combination of activated protein C resistance and antibodies to phospholipids in the development of thrombosis[].Seminars in Hematology.1997
  • 9Ehrenforth S,Radtke KP,Scharrer I.Acquired protein C-resistance in patients with lupus anticoagulants[].Thrombosis and Haemostasis.1995
  • 10Horbach DA,von Oort E,Donders RCJM,et al.Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus[].Thrombosis and Haemostasis.1996

同被引文献35

  • 1[1]Fukudome K, Esmon CT. Identification cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol hem, 1994, 269: 26486-26491.
  • 2[2]Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, et al. The endothelial cell protein C receptor augments protein C activation by the thrombinthrombomodulin complex. Proc Natl Acad Sci USA, 1996, 93: 10212-10216.
  • 3[3]Esmon CT, Xu J, Gu JM, et al. Endothelial protein C receptor.Thrombosis and Haemostasis, 1999, 82: 251-258.
  • 4[4]Kurosawa S, Stearns-urosawa DJ, Hiadri N, et al. Identification of functional endothelial protein C receptor in human plasma. J Clin Invest, 1997, 100:411-418.
  • 5[5]Fukudome K, Ye X, Tsuneyoshi N, et al. Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor. J Exp Med, 1998, 187:1029-1035.
  • 6[6]Laszik Z, Mitro A, Taylor FB, et al. Human protein C receptor is pressent primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation, 1997, 96: 3633-3640.
  • 7[8]Kurosawa S, Stearns-Kurosawa DJ, Carson CW, et al. Plasma levels of endothelial cell protein C receptor are elevated in patients with sepis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes(letter). Blood,1998, 91:724-728.
  • 8[9]Franchi FP, Faioni EM, Biguzzi E, et al. Expression of gene involved in hemostasis and cell adhesion in human coronary atherosclerotic plaques. Thromb and Haemost, 1999, (Suppl) :445.
  • 9Boehme MW, Raeth U, Galle PR, et al. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythmatosus (SEE): advantage over established serological parameters to indicate disease activity. Clin Exp Immunol, 2000, 119: 189-195.
  • 10Junzo N, Hirohiko K, Etsuji S, et al. Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Br J Haemato, 2001, 114: 647-654.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部